Robotic Joint Replacement Surgery - Less Invasive, Highly Successful.

Proactive Care, Heartfelt Impact— Advancing Heart Failure Management at Home.

Cardiovascular Disease Shouldn't Go Undetected For Women. More Accurate Solutions For Life-Saving Care.

Coronary Artery Disease Diagnosed And Treated - Now With Confidence.

Active Epileptic Seizures Can Now Be Terminated On Demand.

Lupus Nephritis Can Be Devastating. LUPKYNIS™ - Reducing The Need For Kidney Transplants.

Disruptive Cancer Therapies - Made To Make A Difference.

Chemotherapy Without Destroying Your Immune System? COSELA® (trilaciclib) Has It Conquered.

No Longer A Chronic Life-Long Disease - Hepatitis C Cured.

Robotic Joint Replacement Surgery - Less Invasive, Highly Successful.

Proactive Care, Heartfelt Impact— Advancing Heart Failure Management at Home.

Performance is More Than Just Great Returns To Our Investors. It Is Also Measured By Impact.

Venture capital Canada
40+ Diseases Targeted
Lumira Biotech Venture Capital Firm Canada
35+ Approved Products
Ontario Venture Capital Life Sciences
$75+ Billion Cumulative Revenue from Approved Products
Lumira Capital Venture Capital in Canada
Over 5 Million Patients Treated
Venture Capital Life Sciences
$6+ Billion Capital Raised by Portfolio Companies
Scroll to Top